Gmi Research

 The Gene Editing Market is expected to grow exponentially by 2031, fueled by advancements in biotechnology, the development of new gene-editing technologies, and their expanding applications across healthcare, agriculture, and other sectors. As the market continues to evolve, key factors such as the rise of gene therapies, agricultural innovation, and increasing investments in research will play a significant role in shaping its growth trajectory. Growing Demand for Gene Therapies One of the most important factors contributing to the growth of the gene editing market is the increasing demand for gene therapies. Over the past decade, the potential for gene editing to treat or even cure genetic diseases has led to a surge in research and clinical trials. By directly targeting and modifying defective genes, gene editing offers a groundbreaking approach to addressing conditions such as cystic fibrosis, sickle cell anemia, and certain types of cancer. By 2031, gene-editing-based...

Gene Editing Market was valued at USD 3.1 billion in 2021 and is projected to reach USD 9.0 billion in 2029, growing at a significant CAGR of 14.3% during 2022-2029. The factors driving the growth of Gene Editing Market includes increasing application of genomics in drug discovery, agriculture and identifying human genetic disorders, introduction of next-generation sequencing, growing prevalence of infectious diseases and cancer and improvements in the living standards. According to the report published by National Library of Medicine (NLB), the total cases of cancer in India was calculated around 0.589 million in 2011 and is expected to reach 0.934 million by the end of 2026, which will accelerate the demand for gene editing solutions in the approaching years. Moreover, technological innovations in gene-editing tools, rise in Government’s funding to the medical institutes for genetic research, expansion of the pharmaceutical industry, growing number of clinical trials for gene and st...